40 participants
T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-07-01
- Start Date:
- 2023-10-25
- Completion:
- 2027-01-10
Conditions
- HER2-positive Advanced Breast Cancer
Interventions
- DRUG
No Results Yet